Phase I/II Trial of Nivolumab With Radiation or Nivolumab and Ipilimumab With Radiation for the Treatment of Intracranial Metastases From Non-small Cell Lung Cancer
Phase of Trial: Phase I/II
Latest Information Update: 20 Feb 2017
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 19 Dec 2016 Status changed from not yet recruiting to recruiting.
- 23 Sep 2016 Planned primary completion date changed from 1 Jun 2020 to 1 Dec 2020.
- 23 Sep 2016 Planned initiation date changed from 1 Jun 2016 to 1 Dec 2016.